Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$83.14 - $145.99 $665 - $1,167
-8 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$98.85 - $138.91 $494 - $694
-5 Reduced 38.46%
8 $1,000
Q1 2021

May 06, 2021

SELL
$64.07 - $91.75 $512 - $734
-8 Reduced 38.1%
13 $1,000
Q4 2020

Feb 03, 2021

SELL
$65.07 - $98.24 $65 - $98
-1 Reduced 4.55%
21 $2,000
Q2 2020

Aug 14, 2020

SELL
$29.01 - $74.23 $203 - $519
-7 Reduced 24.14%
22 $2,000
Q4 2019

Feb 14, 2020

SELL
$40.86 - $57.65 $531 - $749
-13 Reduced 30.95%
29 $2,000
Q3 2019

Nov 14, 2019

BUY
$37.38 - $49.47 $37 - $49
1 Added 2.44%
42 $2,000
Q3 2018

Nov 13, 2018

SELL
$32.79 - $43.0 $229 - $301
-7 Reduced 14.58%
41 $2,000
Q1 2018

May 14, 2018

BUY
$22.49 - $34.56 $1,079 - $1,658
48 New
48 $1,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.56B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.